跳到正文

礼来

争议事件

以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。

返回词条共 2 条

  1. 2026

    患者就与Mounjaro和Trulicity相关的胃部问题起诉礼来

    提起诉讼

    据《Indiana Lawyer》报道,一名患者起诉礼来(Eli Lilly),称其胃部问题与药物Mounjaro和Trulicity有关。该事件于2026年10月8日被报道。诉讼涉及该患者声称的与这两种药物相关的胃部问题。来源未提供有关结果或其他指控的进一步细节。

    当事方说明的目的. 阻止假冒瑞他鲁肽的销售

    品牌回应

    • 否认 — Eli Lilly

      In an emailed statement, a spokesperson for Eli Lilly called the complaint “baseless”
    • 否认 — CVS

      Spokespersons for CVS and Novo Nordisk said they intend to “vigorously defend” against the claims in the lawsuit.
    • 否认 — Novo Nordisk

      Spokespersons for CVS and Novo Nordisk said they intend to “vigorously defend” against the claims in the lawsuit.
    • 否认 — Sanofi

      Sanofi said its pricing practices have “always complied with the law.”

    来源摘录

    • Eli Lilly sued over stomach problems patient ties to Mounjaro and Trulicity
    • Caleb Amick, The Indiana Lawyer
    • On Aug. 12, Eli Lilly announced it had filed six lawsuits against companies that it claims are illegally selling retatrutide.
  2. 2026

    礼来前销售代表因涉嫌推广Mounjaro提起诉讼

    提起诉讼

    礼来前销售代表Jennifer Mansion起诉该公司,称她反对礼来涉嫌将Mounjaro用于减重的推广后遭到报复。诉状称该用途当时尚未获批。报复指控仍属指称,并非已确立的法院认定。

    来源摘录

    • An alleged Mounjaro marketing dispute is at the center of former Eli Lilly and Co. sales representative Jennifer Mansion's lawsuit, which accuses the company of retaliation after she objected.
    • Mansion's complaint dates the end of her employment to Nov. 9, 2023. It says she had objected to Lilly's alleged promotion of Mounjaro for weight loss.
    • The complaint describes weight loss as a use that had not been approved at the time. The retaliation charge remains Mansion's allegation and is not an established court finding.